Clinical predictors of response to immunotherapy in patients with extensive-stage small cell lung cancer. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does not ...

The FLAURA2 trial showed that combining Tagrisso with chemotherapy improved survival in EGFR-mutated NSCLC, especially in patients with liver metastases and TP53 alterations. Addressing emotional and ...

Diverging paths: Identifying barriers to and increasing accessibility of a survivorship program in a socio-economically diverse community. This is an ASCO Meeting Abstract from the 2025 ASCO Annual ...

Medically reviewed by Doru Paul, MD Key Takeaways Survival rates for stage 3 lung cancer can vary between 13% to 36% depending on the subtype.Stage 3a lung cancer is often treated with surgery and ...

A 69-year-old Greeley woman had just hiked 8 miles in Sedona, Arizona, when she received a call that she had lung cancer. Despite her active lifestyle, a past of smoking crept up on her without any ...

Please provide your email address to receive an email when new articles are posted on . Non-lung secondary cancers can develop in survivors of lung cancer years after completion of definitive therapy.

Research shows that cancer survivors can lower their risk of death with increased physical activity. Here's what Black cancer ...

CLEVELAND — Six years after doctors told him he had lung cancer, Tony Holland walks the halls of Cleveland Clinic Akron General with a unique perspective. The 65-year-old patient transporter doesn't ...

The American Cancer Society’s Cancer Statistics, 2026 report highlights a historic milestone: the 5-year relative survival rate for all cancers combined has reached 70%, up from 49% in the mid-1970s.

You and your family are our top priority. At Fred Hutch Cancer Center, we offer comprehensive and compassionate care — personalized to you. You'll have access to the latest treatment options, clinical ...